Recently, a single-cell study on MCs in pan-cancer classified tumor MCs into two subtypes: anti-tumorigenic MCs, which are characterized by a high TNF/VEGFA expression ratio, and pro-tumorigenic MCs, which are characterized by a low TNF/VEGFA expression ratio [44]. This evidence concerns the gene TNF and cancer.